Morgese, Maria Grazia <br/><br/>
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.  [electronic resource] 

 -  Experimental neurology  Nov 2007 
 - 110-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2007.07.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Arachidonic Acids--metabolism<br/>Basal Ganglia--metabolism<br/>Benzamides--therapeutic use<br/>Benzoxazines--therapeutic use<br/>Cannabinoids--agonists<br/>Capsaicin--analogs & derivatives<br/>Carbamates--therapeutic use<br/>Drug Therapy, Combination<br/>Dyskinesia, Drug-Induced--metabolism<br/>Endocannabinoids<br/>Levodopa--adverse effects<br/>Male<br/>Morpholines--therapeutic use<br/>Naphthalenes--therapeutic use<br/>Oxidopamine<br/>Parkinson Disease, Secondary--chemically induced<br/>Polyunsaturated Alkamides--metabolism<br/>Rats<br/>Rats, Wistar<br/>Receptor, Cannabinoid, CB1--drug effects<br/>TRPV Cation Channels--antagonists & inhibitors